Instinct Bio Reports 1H 2026 Results and Return to Profit
Consumer Goods
Earnings
Merger:
Jul 24, 2026
Industry:
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Show Chart?
Load external content from TradingView!
*You can change or withdraw your consent at any time in the footer under Cookies.
Instinct Bio Returns to Profit and Grows Revenue Nearly 10% in Yen Terms in First Half of Fiscal 2026
Tokyo, Japan. Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT), a developer, manufacturer, and seller of stem-cell-based and regenerative-medicine-related cosmetics and health products, announced its unaudited financial results for the six months ended May 31, 2026.
... Read on — Members only
About INSTINCT BIO TECHNICAL CO HOLDINGS INC.
Instinct Bio is a biotechnology company focused on regenerative medicine, longevity-related technologies and advanced therapeutic platforms. The Company is committed to developing innovative solutions intended to address unmet medical needs and support long-term human health outcomes.
For more information, please visit the Company’s website at https://instinct-biot.com/
More BIOT News
Consumer Goods
Daily overview of upcoming SPAC and IPO events – from initial announcement to definitive agreement and public listing.
Discover last week’s SPAC and IPO highlights, key trends, and market updates. Stay informed with SpacStar.